USANA Health Sciences (NYSE: USNA) — Perfil da empresa, notícias e dados financeiros
USANA Health Sciences develops nutritional supplements and personal care products focused on promoting healthy living.

USANA Health Sciences
USANA Health Sciences (NYSE:USNA) engages primarily in the development, manufacture, and sale of nutritional supplements, healthy foods, and personal care products. Focused on promoting healthy living, their extensive range of products is formulated to support the body's nutritional needs, fostering a global community keen on maintaining wellness and health. USANA's projects span across research and innovation to create scientifically-based products, emphasizing quality and efficacy. The company's objective is to empower individuals to achieve their health goals through superior products, promoting an ethos of wellbeing and preventive care. With operations spreading globally, USANA ensures its offerings meet the rigorous standards set by health authorities around the world, demonstrating a commitment to improving life quality for its customers.
Resumo
Operações
Produtos e/ou serviços de USANA Health Sciences
- CellSentials, comprehensive nutritional supplements including core minerals and vitamins.
- Procosa, a supplement specifically designed to support joint health.
- BiOmega, a high-quality fish oil supplement rich in omega-3 fatty acids.
- HepaPlus, designed to support liver health utilizing innovative nutritional technology.
- MagneCal D, a balanced formula promoting bone health and mineral supplementation.
- Rev3 Energy, a cleaner energy drink alternative formulated with natural caffeine and antioxidants.
equipe executiva do USANA Health Sciences
- Kevin G. GuestCEO & Executive Chairman
- G. Douglas HekkingChief Financial Officer
- Walter NootChief Operating Officer
- P. Joshua FoukasChief Legal Officer, General Counsel & Corporate Secretary
- Brent L. NeidigChief Commercial Officer
- Myron W. WentzFounder & Chairman Emeritus
- John CuomoExecutive Director of Product Development & Technology
- Peter BenedictChief Information Officer
- Kathryn ArmstrongChief Scientific Officer
- Patrique RichardsExecutive Director of Investor Relations & Business Development
Últimas notícias sobre a USANA Health Sciences
Principais indicadores financeiros
Resultados divulgados pela USANA Health Sciences, em USD.
- Cap. de mercado
- 260 mi
- Receita (TTM)
- 913,4 mi
- P/L
- —
- LPA (diluído, TTM)
- -1.2
- Dividend yield
- —
- Margem de lucro
- -2.4%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 925,3 mi | 50,9 mi | 10,8 mi | |
| 854,5 mi | 66,3 mi | 42 mi | |
| 921 mi | 93,1 mi | 63,8 mi | |
| 998,6 mi | 107,6 mi | 69,4 mi |